PICU Admission Lactate and Central Venous Oxymetry Study

Lactate Levels and Venous Oxygen Saturation in Children Admitted to a Dutch PICU

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01696175

Acronym

PALVOS

Enrollment

Registered

2012-09-28

Start date

2012-09-30

Completion date

2017-04-30

Last updated

2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shock

Keywords

ScvO2, venous, oxymetry, lactate, children, PICU, Admission parameters of shock

Brief summary

Observational multicentre cohort study. Children admitted to a Dutch PICU are studied for lactate levels and ScvO2. Children instrumented with arterial and central venous catheters are included within the first 12 hours after admittance.

Detailed description

Rationale: Hemodynamic therapy in children with circulatory insufficiency requires the use of hemodynamic monitoring parameters including parameters that reflect tissue/organ oxygenation and oxygen utilization. Two parameters are readily available at the bedside that may reflect this: arterial lactate level and central venous oxygen saturation (ScvO2). To date is it unknown if these parameters are useful in guiding treatment of critically ill children. Also it is unknown how often lactate and ScvO2 are abnormal in children admitted to a Dutch PICU or if they are related to each. Objective: The objective of this study is to find the incidence of a raised lactate level and or a decreased ScvO2, to study their mutual relation and to study the relation between lactate, ScvO2 and outcome parameters in children admitted to a Dutch PICU. Study design: Observational cohort study Study population: children admitted to a PICU \<= 16 years Intervention (if applicable): No intervention Main study parameters/endpoints: Arterial lactate level, central venous oxygen saturation (ScvO2), arterial blood gas analysis and general hemodynamic variables in the first 24 hours after admission. Parameters for organ dysfunction, severity of illness and outcome parameters like length of PICU stay. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: This is a strict observational design. No blood samples are taken for the purpose of this study. No intravascular catheters are inserted for the purpose of this study. No treatment strategy is associated with this study.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Weeks to 16 Years

Healthy volunteers

Inclusion criteria

* Al children admitted to a PICU \<= 16 years equipped with an arterial and central venous catheter in situ at admission or inserted within \< 12 hours after admission to the PICU

Exclusion criteria

* Patients without an arterial or central venous catheter \> 12 hours after of admission * Patients with a known underlying metabolic disorder causing an elevated lactate level * Patients with asthma and therapy (nebulized or intravenous) with salbutamol. * Patients with an intoxication causing elevated lactate levels * Premature children (\<38 weeks GA) * Patients on ECMO

Design outcomes

Primary

Measure	Time frame	Description
What is the incidence of a decreased ScvO2 and or a raised lactate level in children admitted to Dutch PICU's in the first 24 hours after admission to the PICU	first 24 hours after admission	What is the incidence of a decreased ScvO2 and or a raised lactate level in children admitted to Dutch PICU's in the first 24 hours after admission to the PICU

Countries

Netherlands

Outcome results